Search this website. You can use fund codes to locate specific funds

Takeda Pharmaceutical case study

EOS Engagement Impact

Fast reading

  • Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers.
  • EOS has engaged it on this topic for the past 16 months to increase investor confidence in the company for the long term.

Case studies are shown to demonstrate engagement, EOS does not make any investment recommendations and the information is not an offer to buy or sell securities.

Related Insights

Samsonite case study
Samsonite has launched a sustainability strategy to 2030, including plans to use 100% renewable energy and achieve operational carbon neutrality by 2025.
Battling the superbugs
Misuse and overuse of antibiotics within industrial animal farming is recognised as a leading cause of the rise in AMR.
Playing catch up – the challenge for Japan
How are we engaging with Japanese companies and policymakers to accelerate the energy transition and support women in the workplace?
BP case study
BP has committed to become net-zero by 2050 or sooner, supported by a robust strategy to get there and market-leading disclosures.
Public Engagement Report Q3 2021
In this issue we take a more in-depth look at the climate crisis ahead of COP26.
Running out of time
Since the Paris Agreement was finalised, we have engaged with companies around the globe, urging them to put in place strategies that are consistent with the Paris goals.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS